World Journal of Dentistry

Register      Login

VOLUME 12 , ISSUE 1 ( January-February, 2021 ) > List of Articles


Evaluation of Anosmia and Ageusia in COVID-19 Patients: An Observational Study

Monali R Nikalje, Tulsi Subramaniam, Rajkumar Nikalje

Keywords : Ageusia, Anosmia, COVID-19, Smell disorders, Taste disorders

Citation Information : Nikalje MR, Subramaniam T, Nikalje R. Evaluation of Anosmia and Ageusia in COVID-19 Patients: An Observational Study. World J Dent 2021; 12 (1):3-6.

DOI: 10.5005/jp-journals-10015-1799

License: CC BY-NC 4.0

Published Online: 00-02-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Aim and objective: Chemosensitive disorders are being reported increasingly in coronavirus disease 2019 (COVID-19) patients. An attempt to document the incidence of this variation in the perception of taste, smell, salivation, and burning sensation in the mouth as well as mouth ulcerations in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Materials and methods: A single-institution short-term observational study was conducted on chemosensitive complaints like ageusia, anosmia, decreased salivation, oral ulcers, and burning sensation in the mouth, in patients diagnosed with COVID-19. Results: Among 201 patients, 25.9% of patients reported a loss of smell while 33.3% of patients reported alteration in taste. 27.9% of patients reported decreased salivation, while ulcer findings were only in 1.5% and burning sensation in 1% of the patients. Conclusion: Clinicians should suspect infection of SARS-CoV-2 in such patients, to avoid missing diagnosis or misdiagnosis of these patients which could lead to further transmission and spread of the disease. Clinical significance: Loss of smell and taste seems to be more common in COVID-19 patients as compared to other chemosensitive disorders like ulcers in the mouth or burning sensation or decreased salivation.

PDF Share
  1. Aziz M, Perisetti A, Lee-Smith WM, et al. Taste changes (dysgeusia) in COVID-19: a systematic review and meta-analysis. Gastroenterology. 2020;159(3):1132–1133. DOI: 10.1053/j.gastro.2020.05.003.
  2. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020;277(8):2251–2261. DOI: 10.1007/s00405-020-05965-1.
  3. Vaira LA, Salzano G, Deiana G, et al. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020;130(7):1787. DOI: 10.1002/lary.28692.
  4. Keyhan SO, Fallahi HR, Cheshmi B. Dysosmia and dysgeusia due to the 2019 novel coronavirus; a hypothesis that needs further investigation. Maxillofac Plast Reconstr Surg 2020;42(1):9. DOI: 10.1186/s40902-020-00254-7.
  5. Chary E, Carsuzaa F, Trijolet JP, et al. Prevalence and recovery from olfactory and gustatory dysfunctions in covid-19 infection: a prospective multicenter study. Am J Rhinol Allergy 2020;34(5):686–693. DOI: 10.1177/1945892420930954.
  6. Agyeman AA, Chin KL, Landersdorfer CB, et al. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc 2020;95(8):1621–1631. DOI: 10.1016/j.mayocp.2020.05.030.
  7. Haehner A, Draf J, Dräger S, et al. Predictive value of sudden olfactory loss in the diagnosis of COVID-19. ORL J Otorhinolaryngol Relat Spec 2020;82(4):175–180. DOI: 10.1159/000509143.
  8. Vaira LA, Salzano G, Fois AG, et al. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol 2020;10(9):1103–1104. DOI: 10.1002/alr.22593.
  9. Russell B, Moss C, Rigg A, et al. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: what does the current evidence say. Ecancermedicalscience 2020;14:ed98. DOI: 10.3332/ecancer.2020.ed98.
  10. Smith LTAC, Hodges CDRJ, Pratt M, et al. Case report: COVID-19 patient with chief complaint of anosmia and ageusia; a unique perspective on atypical symptomatology and management in the military. Mil Med 2020;185(11-12):e2176–e2179. DOI: 10.1093/milmed/usaa196.
  11. Patel A, Charani E, Ariyanayagam D, et al. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection. Clin Microbiol Infect. 2020;26(9)):1236–1241. DOI: 10.1016/j.cmi.2020.05.026.
  12. Tanasa IA, Manciuc C, Carauleanu A, et al. Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known. Exp Ther Med 2020;20(3):2344–2347. DOI: 10.3892/etm.2020.8808.
  13. Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: a systematic review. Wellcome Open Res 2020;5:94. DOI: 10.12688/wellcomeopenres.15917.1.
  14. Zhang Q, Shan KS, Abdollahi S, et al. Anosmia and ageusia as the only indicators of coronavirus disease 2019 (COVID-19). Cureus. 2020;12(5):e7918.
  15. Lechien JR, Chiesa-Estomba CM, Hans S, et al. Loss of smell and taste in 2013 European patients with mild to moderate COVID-19. Ann Intern Med 2020;173(8):672–675. DOI: 10.7326/M20-2428.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.